This provider's $24.8M in total Medicare payments ranks in the 96th percentile of Clinical Laboratory providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 184% in 2020
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $113.78 | $44.01 | 2.59x | $69.77 | $1.0M | 24.6K | 20.4K |
| 2015 | $138.10 | $53.35 | 2.59x | $84.75 | $1.3M | 28.2K | 23.5K |
| 2016 | $151.40 | $56.60 | 2.67x | $94.80 | $1.6M | 32.7K | 26.8K |
| 2017 | $161.77 | $58.07 | 2.79x | $103.70 | $1.7M | 35.6K | 29.4K |
| 2018 | $138.67 | $50.08 | 2.77x | $88.59 | $1.8M | 38.8K | 32.0K |
| 2019 | $94.74 | $32.55 | 2.91x | $62.19 | $1.9M | 48.9K | 40.5K |
| 2020 | $87.00 | $30.22 | 2.88x | $56.78 | $5.3M | 96.9K | 70.9K |
| 2021 | $81.92 | $28.25 | 2.90x | $53.67 | $6.0M | 155.3K | 98.4K |
| 2022 | $83.83 | $28.58 | 2.93x | $55.25 | $3.6M | 112.3K | 77.2K |
| 2023 | $81.20 | $28.95 | 2.80x | $52.25 | $628.6K | 28.4K | 24.4K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 93.3K | $7.9M | $84.28 | 2.13x |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | 186.3K | $7.6M | $40.77 | 3.59x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 56.4K | $1.4M | $24.93 | 2.01x |
| 88342 | Tissue or cell analysis by immunologic technique | 18.6K | $1.0M | $54.03 | 2.91x |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 28.9K | $676.2K | $23.38 | 2.22x |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | 7.3K | $626.2K | $86.23 | 2.88x |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | 9.8K | $588.5K | $59.77 | 2.23x |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 2.1K | $588.1K | $282.99 | 3.34x |
| 88341 | Special stained specimen slides to examine tissue | 9.2K | $342.7K | $37.06 | 3.28x |
| 88360 | Microscopic genetic analysis of tumor | 5.2K | $292.1K | $56.43 | 2.46x |
| 88173 | Evaluation of fine needle aspirate with interpretation and report | 3.6K | $259.5K | $72.91 | 2.13x |
| 88108 | Cell examination of specimen | 7.0K | $224.9K | $32.11 | 3.52x |
| 88344 | Special stained specimen slides to examine tissue | 2.7K | $191.6K | $70.21 | 2.52x |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | 9.8K | $177.8K | $18.08 | 4.51x |
| 88333 | Pathology examination of tissue specimen during surgery | 3.2K | $164.2K | $51.58 | 2.22x |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 4.8K | $154.1K | $32.20 | 2.22x |
| 88331 | Pathology examination of tissue during surgery | 2.1K | $135.1K | $64.37 | 2.48x |
| 88309 | Pathology examination of tissue using a microscope, high complexity | 1.0K | $119.9K | $117.55 | 2.14x |
| 80053 | Blood test, comprehensive group of blood chemicals | 10.7K | $112.5K | $10.49 | 2.82x |
| 88189 | Flow cytometry technique for DNA or cell analysis | 1.6K | $104.7K | $67.53 | 4.18x |
This provider submits charges 2.79 times higher than what Medicare actually pays.
A markup ratio of 2.79x means for every $100 Medicare pays, this provider initially charges $279. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in WA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Laboratory Corporation Of America | Seattle, WA | $203.1M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Seattle, WA | $97.9M | ⚠️ Flagged |
| Carenexa, Llc | Vancouver, WA | $70.5M | ✓ Clear |
| Adaptive Biotechnologies Corporation | Seattle, WA | $54.5M | ✓ Clear |
| Regional Toxicology Services, Llc | Tacoma, WA | $37.2M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data